MedTrace Logo

Nutrient Timing Following Resistance Exercise

NCT01674049 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2012-08-29

No results posted yet for this study

Summary

The purpose of the proposed study is to examine the timing of post-exercise feeding on 15 hours post-exercise glycemic control and metabolic flexibility and in overweight and obese young men with a family history of type 2 diabetes.

Aim 1 - To determine the temporal effects of post-exercise feeding (i.e., immediate post-exercise vs. 3 hours post-exercise) on glycemic control, peripheral insulin sensitivity, and metabolic flexibility (as evaluated by sleep RQ) in this same group of participants. We hypothesize that a 3 hour delay in nutrient ingestion will promote significantly greater improvements in glucose tolerance, metabolic flexibility, and peripheral insulin sensitivity both immediately and several hours post-ingestion.

Conditions

Interventions

DIETARY_SUPPLEMENT

Immediate Nutrition

Nutritional supplement consumed either immediately following a 40min resistance exercise bout

DIETARY_SUPPLEMENT

Nutrition 3 hours Post-Bout

Nutritional supplement (600g low-fat chocolate milk) consumed three hours after the exercise bout

OTHER

Resistance Exercise

A single 40 minute circuit-style bout of resistance exercise

Sponsors & Collaborators

  • United States Department of Agriculture (USDA)

    collaborator FED

  • George Washington University

    lead OTHER

Principal Investigators

  • Jean L Gutierrez, PhD · The George Washington University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01674049 on ClinicalTrials.gov